Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Metagenomi Therapeutics, Inc. - Common Stock
(NQ:
MGX
)
1.460
-0.110 (-7.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Metagenomi Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm
September 27, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Metagenomi Inc. (MGX) Investors
September 27, 2024
From
Kirby McInerney LLP
Via
Business Wire
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Metagenomi Inc.
September 27, 2024
From
Robbins LLP
Via
GlobeNewswire
Peeling Back The Layers: Exploring Metagenomi Through Analyst Insights
↗
September 06, 2024
Via
Benzinga
Unveiling 4 Analyst Insights On Metagenomi
↗
August 21, 2024
Via
Benzinga
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm
September 27, 2024
From
Schall Law
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Investors
September 27, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
September 27, 2024
From
Rosen Law Firm
Via
Business Wire
METAGENOMI, INC. (NASDAQ: MGX) INVESTOR ALERT: Investors With Large Losses in Metagenomi, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
September 27, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm
September 20, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
September 19, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
September 03, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
August 29, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Participate in Upcoming Investor Conferences
August 28, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Metagenomi, Target Hospitality, Helios, and LegalZoom and Encourages Investors to Contact the Firm
August 26, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Cogent Communications To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
↗
August 19, 2024
Via
Benzinga
MGX Stock Earnings: Metagenomi Beats EPS, Beats Revenue for Q2 2024
↗
August 14, 2024
MGX stock results show that Metagenomi beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
August 14, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi, Inc. (MGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 11, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Dril-Quip, LPL Financial, Methode, and Metagenomi and Encourages Investors to Contact the Firm
August 05, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Metagenomi, Inc. (MGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 02, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
MGX Investors Have Opportunity to Join Metagenomi, Inc. Securities Fraud Investigation with the Schall Law Firm
July 30, 2024
From
The Schall Law Firm
Via
Business Wire
METAGENOMI ALERT: Bragar Eagel & Squire, P.C. is Investigating Metagenomi, Inc. on Behalf of Metagenomi Stockholders and Encourages Investors to Contact the Firm
July 18, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
July 18, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Metagenomi, Inc. (MGX)
July 17, 2024
From
Kirby McInerney LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
July 17, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
July 16, 2024
From
Law Offices of Frank R. Cruz
Via
Business Wire
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
May 29, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024
↗
May 14, 2024
MGX stock results show that Metagenomi missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
May 14, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
